# Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer

> **NCT00652132** · PHASE3 · COMPLETED · sponsor: **University of Birmingham** · enrollment: 116 (actual)

## Conditions studied

- Liver Cancer
- Ototoxicity

## Interventions

- **DRUG:** cisplatin
- **DRUG:** sodium thiosulfate

## Key facts

- **NCT ID:** NCT00652132
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-15
- **Primary completion:** 2017-09-04
- **Final completion:** 2018-02-28
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2018-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652132, "Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00652132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*